Search research articles
Contact Us
Filters
Showing results (471-480 of 586) with videos related to
Page
of 59
Sort By:
Anticancer Research
|
January 1, 2015
Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses
Dirk Rades, Stefan Huttenlocher, Volker Rudat, et al.
Journal of Radiosurgery and SBRT
|
January 4, 2018
International survey of the treatment of metastatic spinal cord compression
Samuel Ryu, Ernesto Maranzano, Steven E Schild, et al.
International Journal of Molecular Sciences
|
February 5, 2020
EVI1 as a Marker for Lymph Node Metastasis in HNSCC
Christian Idel, Julika Ribbat-Idel, Patrick Kuppler, et al.
BMC Cancer
|
September 17, 2022
Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02)
Dirk Rades, Inga Zwaan, Jon Cacicedo, et al.
Cancers
|
January 25, 2025
Silicone Fiducial Markers Improve Precision in Uveal Melanoma Radiation Therapy
Svenja Rebecca Sonntag, Olaf Wittenstein, Oliver Blanck, et al.
Anticancer Research
|
April 28, 2025
Elevated PD-L1 Expression on Circulating Classical Monocytes Upon Checkpoint Inhibitor Therapy Is Associated With Increased Plasma Interleukin 5 in Patients With Lung Cancer
Eva Probst, Christian Idel, Jonas Fleckner, et al.
Anticancer Research
|
October 3, 2014
Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma
Niklas Gebauer, Tim Tristan Hardel, Judith Gebauer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2010
Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck
Dirk Rades, Stefanie Kronemann, Thekla Meyners, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2006
Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study
Dirk Rades, Silke Tribius, Emre F Yekebas, et al.
Anticancer Research
|
March 31, 2018
Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases
Dirk Rades, Liesa Dziggel, Stefan Janssen, et al.
Page
of 59
Search research articles
Search
Showing results (471-480 of 586) with videos related to
Sort By:
Page
of 59
Anticancer Research
|
January 1, 2015
Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses
Dirk Rades, Stefan Huttenlocher, Volker Rudat, et al.
Journal of Radiosurgery and SBRT
|
January 4, 2018
International survey of the treatment of metastatic spinal cord compression
Samuel Ryu, Ernesto Maranzano, Steven E Schild, et al.
International Journal of Molecular Sciences
|
February 5, 2020
EVI1 as a Marker for Lymph Node Metastasis in HNSCC
Christian Idel, Julika Ribbat-Idel, Patrick Kuppler, et al.
BMC Cancer
|
September 17, 2022
Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02)
Dirk Rades, Inga Zwaan, Jon Cacicedo, et al.
Cancers
|
January 25, 2025
Silicone Fiducial Markers Improve Precision in Uveal Melanoma Radiation Therapy
Svenja Rebecca Sonntag, Olaf Wittenstein, Oliver Blanck, et al.
Anticancer Research
|
April 28, 2025
Elevated PD-L1 Expression on Circulating Classical Monocytes Upon Checkpoint Inhibitor Therapy Is Associated With Increased Plasma Interleukin 5 in Patients With Lung Cancer
Eva Probst, Christian Idel, Jonas Fleckner, et al.
Anticancer Research
|
October 3, 2014
Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma
Niklas Gebauer, Tim Tristan Hardel, Judith Gebauer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2010
Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck
Dirk Rades, Stefanie Kronemann, Thekla Meyners, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2006
Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study
Dirk Rades, Silke Tribius, Emre F Yekebas, et al.
Anticancer Research
|
March 31, 2018
Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases
Dirk Rades, Liesa Dziggel, Stefan Janssen, et al.
Page
of 59